This study is in progress, not accepting new patients
ADH1 and ADH2 Disease Monitoring Study (DMS)
Summary
- Eligibility
- for people ages up to 90 years (full criteria)
- Location
- at UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Calcilytix Therapeutics, Inc., a BridgeBio company
- ID
- NCT05227287
- Study Type
- Observational
- Participants
- About 95 people participating
- Last Updated